Over the last 10 years patent value has eroded little by little, starting first with the lost of a presumptive right to an injunction with the Supreme Court decision in eBay v. MercExchange, then with the enactment of the America Invents Act, which created new administrative trial procedures to challenge patent rights, and ultimately with the Supreme Court’s assault on patent eligibility in Mayo, Myriad and Alice. It has become more difficult to patent biotechnology and software innovations, and those that are patented are much easier to defeat as improvidently granted.
Over the last several months there have been some decisions from the Federal Circuit that raise hope for patent owners, but with a new Congress and Administration just months away the omnipresent calls for patent reform all guaranteed to soon return.
Against this backdrop we will discuss patent valuation and monetization realities in an AIA world. We will take your questions, as well as discuss the following:
- Patent eligibility at the Federal Circuit; reasons for hope.
- The outlook for innovators and patent owners in Q4 2016 and Q1 2017
- Patent Reform: what is likely to happen and how could it impact value and monetization strategies.
Join industry experts, Gene Quinn, Patent Attorney & President of IPWatchdog, and Ashley C. Keller, Managing Director & Co-founder of Gerchen Keller Capital, for some much needed insight and foresight into the current state of patent valuation. They will also open up the discussion to take any questions.
CLICK HERE to register for this free webinar.